研究单位：[1]Chia Tai Tianqing Pharmaceutical Group Co., Ltd.[2]The First Affiliated Hospital, Anhui Medical University[3]Beijing Cancer Hospital[4]Tongji Hospital Tongji Medical College Huazhong University of Science and Technology
研究目的：
The purpose of this study is to compare the effects and safety of Anlotinib with placebo in patients with Gastric Cancer.
